The DCs play a crucial role as aAPCs, and the suppression of MHC-II gene expression by TGF-β hampers the antigen-presenting capacity of DCs in vitro, thereby impacting the anti-tumor immune response (170). The gene discussed is TGFB1; the disease is neoplasm.